In ovarian cancer models, the SCD1 inhibitor BZ36 reduces SCD1 expression and increases cancer cell sensitivity to ferroptosis inducers, thereby inducing tumor cell apoptosis (245). Here, SCD is linked to ovarian carcinoma.